In children under 18 months the prevalence of abnormality was 0.19 on diagnostic tests, and the Denver II had a positive predictive value of 0.36, a negative predictive value of 0.90, a sensitivity of 0.67, and a specificity of 0.72. However, their results should be combined with attention to parental concerns and the pediatrician’s opinion, rather than replacing them, to augment the screening process and increase identification of children with ”. The chairman of the committee wrote: “In the practice of developmental screening and surveillance, we recommend the incorporation of parent-completed questionnaires or directly administered screening tests into the process of surveillance and screening. This list includes the DENVER II among its choices. Frankenburg did not recommend criteria for referral rather, he recommended that screening programs and communities review their results and decide whether they are satisfied.In 2006 the American Academy of Pediatrics Council on Children with Disabilities Section on Developmental Behavioral Pediatrics published a list of screening tests for clinicians to consider when selecting a test to use in their practice. Such factors could include the parents’ education and opinions, the child’s health, family history, and available services. Frankenburg, likened it to a of height and weight and encouraged users to consider factors other than test results in working with an individual child.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |